Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico멕시코 최초의 유행병 이후 전국적으로 대표되는 SARS-CoV-2 항체 유병률 추정치Article Published on 2022-02-012022-09-12 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95%CI age Asymptomatic Blood Blood samples COVID-19 case COVID-19 cases demographic characteristics disease severity epidemic wave Epidemiology estimate First wave group Infection Infectious diseases lockdown maximum measure Measures National Older Outcomes research Prevalence reached SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 seroprevalence Sensitivity and specificity seropositive Seroprevalence social distancing socioeconomic status the immunoassay vaccination Variation virus [DOI] 10.1038/s41467-022-28232-9 PMC 바로가기 [Article Type] Article
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods – United States, December 2020-January 2022이전 SARS-CoV-2 높은 전염 기간과 비교하여 초기 오미크론 변이 기간 동안의 질병 심각도 및 의료 이용 추세 - 미국, 2020년 12월-2022년 1월Comparative Study Published on 2022-01-282022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] 변종, [키워드] addition Admission Admissions appear average B.1.1.529 B.1.617.2 Care cause CDC circulating variant clinically Coverage COVID-19 COVID-19 disease COVID-19 disease severity COVID-19 patient COVID-19 patients Critical database death Delta died disease severity emergency department examined Health Health care Health care system health care systems Health Care Utilization highest hospital Hospital admission Hospital admissions Hospitalization hospitalizations hospitalized COVID-19 patient hospitalized COVID-19 patients hospitals ICU Immunity IMV infections intensive care intensive care unit Invasive mechanical ventilation less Local maximum moving average National nine omicron Omicron variant percentage percentages Period predominant reduce reported SARS-CoV-2 sequenced Severity of disease shown specimen Spread Surveillance the mean the United State The United States Transmission trend United States utilization vaccination variant variant of SARS-CoV-2 virulence virulent virus Volume Winter [DOI] 10.15585/mmwr.mm7104e4 PMC 바로가기 [Article Type] Comparative Study
Misinformation About and Interest in Chlorine Dioxide During the COVID-19 Pandemic in Mexico Identified Using Google Trends Data: Infodemiology StudyOriginal Paper Published on 2022-01-272022-10-30 Journal: Jmir Infodemiology [Category] COVID-19, [키워드] Adverse reaction changes in chlorine chlorine dioxide Compliance coronavirus COVID-19 COVID-19 misinformation COVID-19 pandemic declined Descriptive analysis digital epidemiology dioxide Diseases Dunn test evaluate Evidence Frame Google Google Trends Health Identified identify infodemiology information ingestion interest Internet internet behavior Kruskal-Wallis lack maximum measure mHealth misinformation Mobile health objective organization Pairwise comparison pandemic percentage platform Program promoted public health public health surveillance reached Registered reported restrict Result retrieved risk Safe SARS-COV-2 infection significant changes in significant difference Spanish tele-epidemiology therapy Treatment trend Volume was performed were recorded were used [DOI] 10.2196/29894 PMC 바로가기 [Article Type] Original Paper
Hypercoagulation Detected by Rotational Thromboelastometry Predicts Mortality in COVID-19: A Risk Model Based on a Prospective Observational StudyOriginal Article Published on 2022-01-212022-10-29 Journal: TH Open: Companion Journal to Thrombosis and Haemostasis [Category] COVID-19, [키워드] 30-Day mortality age Analysis anticoagulation clot Coagulation coagulation test Coagulopathy Conventional COVID-19 COVID-19 infection death died disease disease severity eligible evaluate Final for inclusion Hospital admission Hospitalized hospitalized COVID-19 patients Hypercoagulation Hypothesis in vitro Logistic regression longitudinal marker maximum Model Mortality novel coronavirus disease Patient patients hospitalized predict Probability Prospective respiratory frequency Result risk of death SARS-CoV-2 severe disease shown subpopulation suggested therapy Thromboelastometry thrombosis variable was increased [DOI] 10.1055/a-1725-9221 PMC 바로가기 [Article Type] Original Article
Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated PatientsSARS-CoV-2 항체 역가의 측정은 백신 접종을 하지 않은 환자의 기계 학습을 통해 COVID-19 최대 심각도의 예측 정확도를 향상시킵니다Immunology Published on 2022-01-212022-09-11 Journal: Frontiers in Immunology [Category] 진단, 치료법, [키워드] Admission Analysis antibody Antibody Response Antibody responses Antibody testing association best breakthrough infections contribute COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity domain early phase four group four groups help identify IgA IgG IgM intensive care intensive care unit machine learning maximum measurement mechanical ventilatory support nucleocapsid protein Numerous oxygen oxygen supplementation physician prediction Receptor-binding domain required SARS-CoV-2 severity severity of COVID-19 Spike protein suggested symptom onset the antibody response the disease the patient the timing titer titers ventilatory ventilatory support [DOI] 10.3389/fimmu.2022.811952 PMC 바로가기 [Article Type] Immunology
Bayesian Inference of State-Level COVID-19 Basic Reproduction Numbers across the United States미국 전역의 국가 차원의 COVID-19 기본 재생산 수의 베이지안 추론Article Published on 2022-01-152022-09-10 Journal: Viruses [Category] 변종, [키워드] absence acquired immunity approach B.1.617.2 basic basic reproduction number Bayesian Bayesian inference can be used Case report circulating compartmental model Coronavirus disease 2019 (COVID-19) COVID-19 Delta determine disease transmission dominant estimate expected fraction herd immunity Herd immunity threshold immune Immunity in some infection with SARS-CoV-2 infectiousness Inference Lineage mathematical model maximum more difficult Mutation New non-immune number reproduction SARS-CoV-2 SARS-CoV-2 variant secondary case secondary cases seroprevalence survey strain Strains sustained the United State threshold United States unlikely vaccination [DOI] 10.3390/v14010157 PMC 바로가기 [Article Type] Article
Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 20212021년 초 글로벌 COVID-19 대유행이 진행되는 동안 백신 접종률이 낮거나 높은 국가에서 SARS-CoV-2 변이체의 일배체형 분포Article Published on 2022-01-012022-09-11 Journal: Infection, genetics and evolution : journal of mol [Category] SARS, 변종, 유전자 메커니즘, [키워드] A222V A570D acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Analysis Canada characterized Complete coronavirus country COVID-19 outbreak COVID-19 pandemic COVID19 D614G distribution dominant effort Epitopes evade furin furin cleavage site genome sequence Germany group Haplotype haplotypes help Impact India indicated L452R Malaysia maximum Mutation N501Y neutralization new SARS-CoV-2 Nsp12 Ongoing pandemic P323L P681H pandemic Partly vaccinated rate pathogenic profile profiles Profiling Protein proteome proteomes public health Research response to vaccination S982A SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 variant SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 spike Spike protein T19R T478K T716I Taiwan Transmissibility vaccination vaccination rate Vaccination strategies Vaccine-induced immunity variant viral mutation Viral mutations widespread [DOI] 10.1016/j.meegid.2021.105164 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin회복기 혈장 및 혈장 유래 면역글로불린 상업 로트에서의 SARS-CoV-2 중화Article Published on 2022-01-012022-09-12 Journal: BioDrugs : clinical immunotherapeutics, biopharmac [Category] MERS, SARS, 진단, [키워드] analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 antibody average binding domain Comorbidity Concentration convalescent convalescent plasma Course COVID-19 COVID-19 pandemic D614G determine Donor effective ELISA Final heterogeneous population high variability humoral IgG immunization immunodeficiency Immunoglobulin increase in indicated intravenous investigated lot-to-lot variability maximum microneutralization neutralization neutralization capacity Neutralizing Neutralizing antibody titer neutralizing capacity normalized Patient patient population patients pharmacokinetic PID plasma produced profile Protective question RBD reactivity Research Result SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 neutralization serological Standard Support tested the WHO vaccination while [DOI] 10.1007/s40259-021-00511-9 PMC 바로가기 [Article Type] Article
SARS-CoV-2 IgG Surveillance in Asymptomatic Blood Donors and Health WorkersResearch Article Published on 2021-12-292022-10-28 Journal: Advances in Medicine [Category] COVID-19, [키워드] age analyzed antibody Asymptomatic Blood blood donor Blood donors carried chemiluminescence COVID-19 criteria detectable Donor evaluated FDA General population healthcare worker healthy IgG IgG antibody IgG positivity Immunoglobulin India information Isolation Laboratory lack male material maximum Non-COVID-19 parameter Patient PCR plasma positive Precaution Prevalence reactive remained required Result risk SARS-CoV-2 IgG Treatment was performed worker [DOI] 10.1155/2021/2404170 PMC 바로가기 [Article Type] Research Article
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection HistoryBNT162b2-백신 접종 및 감염 이력에 따른 Anti-SARS-CoV-2 면역글로불린 아이소타입 및 바이러스 변이체에 대한 중화 활성Immunology Published on 2021-12-172022-09-11 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, 치료기술, 치료법, [키워드] activity Against anti-RBD Anti-RBD IgG antigen-specific antibody assays B.1 bead BNT162b2 BNT162b2 vaccine both group both groups coronavirus COVID-19 COVID-19 disease COVID‐19 cytopathic delta variant Delta variants disease domain dose expression pattern Fluorescence followed by Gamma highest history IgA IgG IgG levels IgM immunoassay Immunoglobulin immunoglobulins individual maximum mRNA vaccine multiplex immunoassay naïve neutralization Neutralization assay Neutralizing activity neutralizing capacity neutralizing titers Nucleocapsid proteins plasma post-symptom onset provided RBD Result SARS-CoV-2 SARS-CoV-2 antigen Serological assay single vaccine subject subjects suggested Support symptom onset three groups vaccination Vaccine variants Vero E6 Viral Viral antigen was determined [DOI] 10.3389/fimmu.2021.793191 PMC 바로가기 [Article Type] Immunology